, and human T cell leukemia virus has been identified in some patients (9) (10) (11) (12) . Patients with AIDS have T lymphocyte abnormalities including: (a) a reduced percentage of T3' cells in the peripheral blood; (b) inverted ratios of T4+/T8' cells; and (c) defective cellular immune functions (1) (2) (3) (4) (5) (6) 13) . In vitro T lymphocyte responses to specific antigens and mitogens are reduced and natural killer cell activity is decreased (6, 14) . HLA-DR upon blood monocytes, human fetal monocytes, several myeloid leukemic cell lines, and endothelial cells (20) (21) (22) .
In both humans and mice, the ability of T cells to respond to antigen is totally dependent upon interaction with class II MHC positive accessory cells (23) (24) (25) (26) (27) . In the absence of such class II positive accessory cells, T cells fail to respond to viruses or nominal antigens; however, T cell function is restored by the addition of Ia' cells (27) (28) . Since the HLA-DR antigen is a marker for human Ia, the absence of HLA-DR' accessory cells could, in theory, cause a complete collapse in cellular immunity which would be reflected as a defect in the ability of T cells to respond to antigens. Consequently, we have examined HLA-DR on monocytes from patients with AIDS. Using a system that detects two-color fluorescence by cytofluorometry, we determined that monocytes harvested from the circulating blood of AIDS patients express reduced levels of HLA-DR.
The availability of recombinant DNA produced human IFN-y allows us to consider this as a therapeutic modality. Because IFN-y, a product of activated T cells, increases the expression of HLA-DR (20) (21) (22) we incubated monocytes obtained from patients with AIDS with cloned human IFN-'y. We found that in vitro treatment of monocytes obtained from AIDS patients with the cloned human IFN-y increased the expression of HLA-DR to near-normal levels.
Methods
Subjects. The patients studied were homosexual men or intravenous drug users diagnosed as having AIDS or lymphadenopathy. The diagnoses and laboratory findings for patients with AIDS are listed in Table I . All patients with AIDS had biopsy proven pneumocystis pneumonia and/or Kaposi's sarcoma. Patients with the lymphadenopathic syndrome were homosexual men with unexplained persistent lymphadenopathy (>3 mo) in two or more extrainguinal sites without obvious infection. At the time of study none was receiving interferon or steroids (or other agents known to affect T cell function) except as noted (Table I) (Table II) . The data derived from double staining of HLA-DR and M02 on cells from eight normal individuals, four patients with lymphadenopathy, and six patients with AIDS is shown in Fig. 1 . (Fig. 1) HLA-DR expression on monocytes from four patients with lymphadenopathy were similar to or higher than those for normal subjects, with a range of HLA-DR' monocytes between 58 to 97.4%, and mean±SD of 86.2±18.9% (Fig. 1) . Three of these four analyzed patients had >90% HLA-DR+ monocytes.
Of the six patients with AIDS, four had <50% HLA-DR+ monocytes (Fig. 1) (Table III ). In the case of patients with AIDS, where HLA-DR expression was low, treatment with IFN-y caused an increase in HLA-DR to near-normal levels (Table III) . The average for (Table III) .
As previously reported we found that IFN-y also increased HLA-DR expression on normal cells (20) (21) (22) (23) (24) (25) (26) (27) , and are instrumental in triggering the mixed lymphocyte (24) and graft-vs.-host reactions (38) . Three types of human Ia (class II MHC) molecules have been identified and biochemically characterized: DR, DS (or DC), and SB (39, 40) . DR and SB molecules are structurally different but both show sequence homology with murine I-E molecules, whereas DS (DC) is homologous to mouse Ia (39, 40) . Gonwa et al. (41) reported that a population of monocytes expressing both DR and DS (or DC) was more efficient in antigen presentation in autologous mixed lymphocyte reactions than were monocytes that expressed only the DR antigen. Whether the antigen responsible for the ability to interact with T cells is HLA-DR or the concomitantly expressed DS (DC) has not been established. Although we made no attempt in these studies to measure DS (DC) expression, immune interferon (IFN-y) induces expression of both DR and DS (DC) antigens (20, 21, 42) . Recent data indicate that IFN-y may increase DS (DC) expression even more than DR (42) . Also, we have not specifically examined different adherent cell subpopulations. It is possible that T cell function is affected by class II antigen expression on subpopulations of monocytes (41) or on dendritic cells (43) .
In severe combined immunodeficiency of Arabian foals, a disease sharing features with severe combined immunodeficiency in children, elaboration, of IFN-'y by T cells is defective (44) . It has been suggested that the IFN-'y defect may be responsible for the immunodeficiency. It is possible that a deficiency of class II positive monocytes, such as we found for patients with AIDS, and a resultant lack of T cell stimulation could eventually lead to a deficiency in secretion of IFN-'y.
A number of factors that regulate T cell immune responses, such as interferons and IL-2, are secreted by specific T cell subsets (45) . In AIDS, secretion of such lymphokines may be greatly decreased. The production of IL-2 is defective in AIDS patients (14, 46) and it is noteworthy that IL-2 is the primary stimulus causing IFN-y release from immune T cells (47) (48) (49) 
